Skip to main content

Advertisement

SpringerLink
Log in

Clinical research on the combined use of systemic chemotherapy and CT-guided radiofrequency ablation in treatment of lung cancer

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

The purpose of this study is to describe the clinical efficacy and safety of the combined use of systemic chemotherapy and CT-guided radiofrequency ablation (RFA) in treatment of lung cancer. A panel of 256 patients with lung cancer who were admitted to our hospital from June 2017 to October 2019 were recruited. According to the treatment plan, the patients were divided into test group (n = 128) and control group (n = 128). Patients in the test group were treated by systemic chemotherapy combined with CT-guided RFA, while patients in the control group were given systemic chemotherapy only. After treatment, a comparative analysis was conducted in terms of clinical efficacy, level of tumor markers, and adverse reactions. Meanwhile, patients in the two groups were followed up for analysis of progression-free survival (PFS) and overall survival (OS). After treatment, the tumor objective response rate and disease control rate of patients in the test group were significantly higher than those in the control group. Besides, in patients of the test group, tumor markers, such as serum carcino-embryonic antigen, neuro-specific enolase, cytokeratin-19, and carbohydrate antigen-199, presented a remarkably lower level relative to those in the control group (p < 0.05). However, there was no significant difference observed with regard to the incidence of complications (p > 0.05). Additionally, patients in the test group were more likely to have better PFS and OS. Notably, we monitored that in the test group, superior clinical efficacy was achieved in patients with non-small cell lung cancer and lung adenocarcinoma relative to that in patients with small cell lung cancer and lung squamous cell carcinoma, respectively. The combined use of systemic chemotherapy and CT-guided RFA can produce good clinical efficacy in treatment of lung cancer. It is relatively safe and deserves promotion and application in clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The data used to support the findings of this study are available from the corresponding author upon request.

References

  1. Inamura K (2017) Major Tumor suppressor and oncogenic non-coding RNAs: clinical relevance in lung cancer. Cells 6. https://doi.org/10.3390/cells6020012

  2. Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. https://doi.org/10.3322/caac.20107

    Article  Google Scholar 

  3. Barthelmess S et al (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184:1209–1218. https://doi.org/10.1016/j.ajpath.2013.12.016

    Article  CAS  PubMed  Google Scholar 

  4. Strohecker AM, White E (2014) Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Autophagy 10:384–385. https://doi.org/10.4161/auto.27320

    Article  CAS  PubMed  Google Scholar 

  5. Vaughn C, Mychaskiw G 2nd, Sewell P (2002) Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg 94:1149–1151; table of contents. https://doi.org/10.1097/00000539-200205000-00016

    Article  PubMed  Google Scholar 

  6. Karsli-Uzunbas G et al (2014) Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov 4:914–927. https://doi.org/10.1158/2159-8290.CD-14-0363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Wan Y, Sheng D, Qinghua YUJJ o. C. S. Complications of radiofrequency ablation for lung cancer:a retrospective analysis of 160 cases. (2015)

  8. Hui LI et al (2015) CT-guided radiofrequency ablation for the treatment of advanced non-small cell lung cancer: observation of clinical short-term efficacy

  9. Zhi XY, Yu JM, Shi YK (2015) Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version). Cancer 121(Suppl 17):3165–3181. https://doi.org/10.1002/cncr.29550

    Article  PubMed  Google Scholar 

  10. Therasse P et al New guidelines to evaluate the response to treatment in solid tumors. 92:205–216

  11. Oxnard GR et al (2014) Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res 20:1698–1705. https://doi.org/10.1158/1078-0432.CCR-13-2482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Song Q et al (2014) miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM. Cancer Res 74:3031–3042. https://doi.org/10.1158/0008-5472.CAN-13-2193

    Article  CAS  PubMed  Google Scholar 

  13. Faubert B et al (2014) Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1alpha. Proc Natl Acad Sci U S A 111:2554–2559. https://doi.org/10.1073/pnas.1312570111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang Y, Li W, He X, Li G, Xu L (2014) Computed tomography-guided core needle biopsy of lung lesions: diagnostic yield and correlation between factors and complications. Oncol Lett 7:288–294. https://doi.org/10.3892/ol.2013.1680

    Article  PubMed  Google Scholar 

  15. Ng CS, Gonzalez-Rivas D, D’Amico TA, Rocco G (2015) Uniportal VATS-a new era in lung cancer surgery. J Thorac Dis 7:1489–1491. https://doi.org/10.3978/j.issn.2072-1439.2015.08.19

    Article  PubMed  PubMed Central  Google Scholar 

  16. Feng M et al (2014) Uniportal video assisted thoracoscopic lobectomy: primary experience from an eastern center. J Thorac Dis 6:1751–1756. https://doi.org/10.3978/j.issn.2072-1439.2014.11.20

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mu JW et al (2015) A matched comparison study of uniportal versus triportal thoracoscopic lobectomy and sublobectomy for early-stage nonsmall cell lung Cancer. Chin Med J 128:2731–2735. https://doi.org/10.4103/0366-6999.167298

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cai K et al (2014) Unidirectionally progressive resection of left upper pulmonary lobe under video-assisted thoracoscopy. J Thorac Dis 6:1843–1847. https://doi.org/10.3978/j.issn.2072-1439.2014.12.26

    Article  PubMed  PubMed Central  Google Scholar 

  19. Shao W et al (2014) Safety and feasibility of video-assisted thoracoscopic surgery for stage IIIA lung cancer. Chin J Cancer Res 26:418–422. https://doi.org/10.3978/j.issn.1000-9604.2014.08.05

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T (2010) Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer. Anticancer Res 30:3099–3102

    CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Key R&D Projects of Hebei Province (Grant No. 18277781D).

Author information

Author notes

  1. Feng Xu and Zhigang Cai contributed equally to this work.

Authors and Affiliations

  1. Department of Pulmonary and Critical Care Medicine, Cangzhou People’s Hospital, No.7, Qingchi Avenue, Xinhua District, Cangzhou, 061000, Hebei, China

    Feng Xu, Jian Song, Haiyan Liu, Xuanmei Li, Aibing Deng & Jun Chen

  2. Department of Pulmonary and Critical Care Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, 050005, China

    Zhigang Cai

  3. Tianjin Medical University, Tianjin, 300070, China

    Beizheng Xu

  4. Shanghai Engineering Research Center of Pharmaceutical Translation, Shanghai, 200000, China

    Xiaotang Wu

Authors
  1. Feng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhigang Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beizheng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jian Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haiyan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xuanmei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aibing Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiaotang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Not applicable.

Corresponding author

Correspondence to Jun Chen.

Ethics declarations

Ethics approval and consent to participate

This study was conducted in accordance with the Helsinki declaration and was approved by the institutional review boards of our hospital.

Competing interests

The authors declare that they have no conflict of interest.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Highlight

1. Systemic chemotherapy combined with CT-guided radiofrequency ablation produces superior efficacy relative to systemic chemotherapy;

2. Systemic chemotherapy combined with CT-guided radiofrequency ablation is of good safety;

3. Systemic chemotherapy combined with CT-guided radiofrequency ablation can significantly prolong the survival time of patients with lung cancer;

4. Systemic chemotherapy combined with CT-guided radiofrequency ablation is more effective in patients with non-small cell lung cancer and lung adenocarcinoma than in patients with small cell lung cancer and lung squamous cell carcinoma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, F., Cai, Z., Xu, B. et al. Clinical research on the combined use of systemic chemotherapy and CT-guided radiofrequency ablation in treatment of lung cancer. Lasers Med Sci 37, 233–239 (2022). https://doi.org/10.1007/s10103-020-03222-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-020-03222-9

Keywords

Search

Navigation